CRISPR THERAPEUTICS AG (CRSP) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:CRSP • CH0334081137

48.74 USD
+2.86 (+6.23%)
At close: Feb 6, 2026
48.79 USD
+0.05 (+0.1%)
After Hours: 2/6/2026, 8:26:35 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CRSP revenue by date.CRSP revenue by date.
1.2M
-99.87%
371.206M
30,833.83%
37.314M
-89.95%
7.443M
-80.05%
117.46M
1,478.13%
276.25M
135.19%
838.88M
203.67%
2.588B
208.51%
6.629B
156.14%
1.287B
-80.59%
1.622B
26.03%
2.133B
31.50%
EBITDA
YoY % growth
CRSP ebitda by date.CRSP ebitda by date.
-649M
-265.77%
-202.701M
68.77%
-447.307M
-120.67%
-562.103M
-25.66%
-444.079M
21.00%
-436.248M
1.76%
-12.817M
97.06%
258.36M
2,115.71%
463.08M
79.24%
913.92M
97.36%
1.356B
48.37%
N/A
EBIT
YoY % growth
CRSP ebit by date.CRSP ebit by date.
-673.2M
-280.24%
-222.538M
66.94%
-466.566M
-109.66%
-622.794M
-33.48%
-450.253M
27.70%
-360.276M
19.98%
-121.624M
66.24%
434.09M
456.91%
241.69M
-44.32%
555.67M
129.91%
820.01M
47.57%
1.224B
49.27%
Operating Margin
CRSP operating margin by date.CRSP operating margin by date.
-56,100.00%-59.95%-1,250.38%-8,367.51%-383.32%-130.42%-14.50%16.77%3.65%43.18%50.56%57.38%
EPS
YoY % growth
CRSP eps by date.CRSP eps by date.
-8.37
-289.37%
-1.96
76.58%
-4.37
-122.96%
-6.30
-44.15%
-4.07
35.35%
-3.33
18.24%
-2.01
39.57%
0.25
112.53%
2.71
974.75%
6.04
122.81%
8.55
41.65%
13.03
52.46%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-1.17
-166.93%
-1.12
28.99%
-1.12
12.83%
-1.05
9.99%
-1.03
12.60%
Revenue
Q2Q % growth
4.327M
-87.88%
2.474M
186.01%
3.871M
333.97%
17.026M
1,815.19%
21.877M
405.59%
EBITDA
Q2Q % growth
-127.196M
-180.61%
-91.266M
36.48%
-110.256M
10.86%
-119.534M
-1.09%
N/A
EBIT
Q2Q % growth
-124.091M
-92.13%
-114.531M
22.84%
-116.869M
12.18%
-109.878M
16.80%
-123.807M
0.23%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.17
-15.84%
-1.280.118.57%
Q2 2025
Q2Q % growth
-1.29
13.42%
-1.450.1611.00%
Q1 2025
Q2Q % growth
-1.58
-10.49%
-1.28-0.30-23.86%
Q4 2024
Q2Q % growth
-0.44
-140.00%
-1.190.7563.08%
Q3 2024
Q2Q % growth
-1.01
28.37%
-1.450.4430.41%
Q2 2024
Q2Q % growth
-1.49
-52.04%
-1.550.064.06%
Q1 2024
Q2Q % growth
-1.43
-113.43%
-1.36-0.07-5.19%
Q4 2023
Q2Q % growth
1.10
178.01%
-0.071.171,593.05%
Q3 2023
Q2Q % growth
-1.41
37.05%
-1.990.5829.13%
Q2 2023
Q2Q % growth
-0.98
59.17%
-2.161.1854.63%
Q1 2023
Q2Q % growth
-0.67
71.12%
-1.741.0761.43%
Q4 2022
Q2Q % growth
-1.41
23.37%
-2.350.9439.87%
Q3 2022
Q2Q % growth
-2.24
-34.13%
-2.340.104.11%
Q2 2022
Q2Q % growth
-2.40
-125.42%
-2.27-0.13-5.64%
Q1 2022
Q2Q % growth
-2.32
-53.64%
-1.98-0.34-17.46%
Q4 2021
Q2Q % growth
-1.84
-22.67%
-1.80-0.04-1.98%
Q3 2021
Q2Q % growth
-1.67
-26.52%
-1.790.126.77%
Q2 2021
Q2Q % growth
9.44
826.15%
3.595.85162.72%
Q1 2021
Q2Q % growth
-1.51
-31.30%
-1.50-0.01-0.53%
Q4 2020
Q2Q % growth
-1.50 -1.30-0.20-15.52%
Q3 2020
Q2Q % growth
-1.32 -1.21-0.11-9.22%
Q2 2020
Q2Q % growth
-1.30 -0.97-0.33-34.71%
Q1 2020
Q2Q % growth
-1.15 -1.07-0.08-7.34%
CRSP Yearly EPS VS EstimatesCRSP Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
889K
47.67%
9.082M-8.193M-90.21%
Q2 2025
Q2Q % growth
892K
72.53%
6.38M-5.488M-86.02%
Q1 2025
Q2Q % growth
865K
71.63%
6.628M-5.763M-86.95%
Q4 2024
Q2Q % growth
35.691M
-82.26%
8.044M27.647M343.70%
Q3 2024
Q2Q % growth
602K 6.944M-6.342M-91.33%
Q2 2024
Q2Q % growth
517K
-99.26%
3.609M-3.092M-85.67%
Q1 2024
Q2Q % growth
504K
-99.50%
27.076M-26.572M-98.14%
Q4 2023
Q2Q % growth
201.206M 134.27M66.936M49.85%
Q3 2023
Q2Q % growth

-100.00%
8.117M-8.117M-100.00%
Q2 2023
Q2Q % growth
70M
34,900.00%
1.742M68.258M3,918.37%
Q1 2023
Q2Q % growth
100M
11,011.11%
23.44M76.56M326.62%
Q4 2022
Q2Q % growth

-100.00%
7.265M-7.265M-100.00%
Q3 2022
Q2Q % growth
100K
-87.50%
1.649M-1.549M-93.94%
Q2 2022
Q2Q % growth
200K
-99.98%
2.105M-1.905M-90.50%
Q1 2022
Q2Q % growth
900K
80.00%
2.82M-1.92M-68.09%
Q4 2021
Q2Q % growth
12.9M
3,125.00%
2.318M10.582M456.51%
Q3 2021
Q2Q % growth
800K
700.00%
1.145M-345K-30.13%
Q2 2021
Q2Q % growth
900.7M 429.34M471.36M109.79%
Q1 2021
Q2Q % growth
500K
150.00%
1.159M-659K-56.86%
Q4 2020
Q2Q % growth
400K 2.372M-1.972M-83.14%
Q3 2020
Q2Q % growth
100K 2.066M-1.966M-95.16%
Q2 2020
Q2Q % growth
18.488M-18.488M-100.00%
Q1 2020
Q2Q % growth
200K 3.103M-2.903M-93.55%
CRSP Yearly Revenue VS EstimatesCRSP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS3.14% -2.6% 0.39% 0.26%
Revenue-20.31% -75.97% -52.23% -74.9%